149 related articles for article (PubMed ID: 20929403)
1. Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery.
Kim TH; Lim JA; Ahn HY; Lee EK; Min HS; Won Kim K; Choi YH; Park YJ; Park DJ; Kim KH; Youn YK; Cho BY
Thyroid; 2010 Nov; 20(11):1229-34. PubMed ID: 20929403
[TBL] [Abstract][Full Text] [Related]
2. Surgeon-performed ultrasound predictors of malignancy in patients with Hürthle cell neoplasms of the thyroid.
Parikh PP; Allan BJ; Lew JI
J Surg Res; 2013 Sep; 184(1):247-52. PubMed ID: 23535112
[TBL] [Abstract][Full Text] [Related]
3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
4. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
5. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules.
Lee KH; Shin JH; Ko ES; Hahn SY; Kim JS; Kim JH; Oh YL
Int J Surg; 2013; 11(9):898-902. PubMed ID: 23916366
[TBL] [Abstract][Full Text] [Related]
7. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
8. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic lobectomy is not routinely required to exclude malignancy in thyroid nodules greater than four centimetres.
Raj MD; Grodski S; Woodruff S; Yeung M; Paul E; Serpell JW
ANZ J Surg; 2012; 82(1-2):73-7. PubMed ID: 22507501
[TBL] [Abstract][Full Text] [Related]
10. Thyroid lobectomy for indeterminate FNA: not without consequences.
Balentine CJ; Domingo RP; Patel R; Laucirica R; Suliburk JW
J Surg Res; 2013 Sep; 184(1):189-92. PubMed ID: 23777982
[TBL] [Abstract][Full Text] [Related]
11. Is nodule size an independent predictor of thyroid malignancy?
McHenry CR; Huh ES; Machekano RN
Surgery; 2008 Dec; 144(6):1062-8; discussion 1068-9. PubMed ID: 19041019
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms.
Lubitz CC; Faquin WC; Yang J; Mekel M; Gaz RD; Parangi S; Randolph GW; Hodin RA; Stephen AE
Thyroid; 2010 Jan; 20(1):25-31. PubMed ID: 20025540
[TBL] [Abstract][Full Text] [Related]
13. Higher body mass index and larger waist circumference may be predictors of thyroid carcinoma in patients with Hürthle-cell lesion/neoplasm fine-needle aspiration diagnosis.
Arduc A; Dogan BA; Tuna MM; Tutuncu Y; Isik S; Berker D; Guler S
Clin Endocrinol (Oxf); 2015 Sep; 83(3):405-11. PubMed ID: 25296952
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of the thyroid nodule: patient selection based on the results of fine-needle aspiration cytology.
Bouvet M; Feldman JI; Gill GN; Dillmann WH; Nahum AM; Russack V; Robbins KT
Laryngoscope; 1992 Dec; 102(12 Pt 1):1353-6. PubMed ID: 1453841
[TBL] [Abstract][Full Text] [Related]
15. Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm".
Kim ES; Nam-Goong IS; Gong G; Hong SJ; Kim WB; Shong YK
Korean J Intern Med; 2003 Jun; 18(2):94-7. PubMed ID: 12872446
[TBL] [Abstract][Full Text] [Related]
16. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.
Tuttle RM; Lemar H; Burch HB
Thyroid; 1998 May; 8(5):377-83. PubMed ID: 9623727
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
18. Can fine-needle aspiration biopsy of thyroid nodule help in determining the extent of surgery in follicular and Hurthle cell neoplasm at a community teaching institution?
Hawasli A; Rizzo P; Khoury H; McCaffrey JL
Am Surg; 2002 Oct; 68(10):907-10. PubMed ID: 12412723
[TBL] [Abstract][Full Text] [Related]
19. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid.
Sippel RS; Elaraj DM; Khanafshar E; Zarnegar R; Kebebew E; Duh QY; Clark OH
World J Surg; 2008 May; 32(5):702-7. PubMed ID: 18224463
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology.
Baloch ZW; Fleisher S; LiVolsi VA; Gupta PK
Diagn Cytopathol; 2002 Jan; 26(1):41-4. PubMed ID: 11782086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
